Compliance with Prescription Guidelines for Glucose-Lowering Therapies According to Renal Function: Real-Life Study in Inpatients of Internal Medicine, Endocrinology and Cardiology Units

Background and objectives: Renal failure is a contraindication for some glucose-lowering drugs and requires dosage adjustment for others, particularly biguanides, sulfonylureas, and inhibitors of dipeptidyl peptidase 4. In this study, we assessed adherence to prescription recommendations for glucose...

Descripción completa

Detalles Bibliográficos
Autores principales: Lohan, Laura, Galtier, Florence, Manson, Thibault, Mura, Thibault, Castet-Nicolas, Audrey, Faure, Delinger, Chapet, Nicolas, Leclercq, Florence, Pasquié, Jean Luc, Roubille, François, Roubille, Camille, Blain, Hubert, Guilpain, Philippe, Villiet, Maxime, Avignon, Antoine, Sultan, Ariane, Breuker, Cyril
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704212/
https://www.ncbi.nlm.nih.gov/pubmed/34946320
http://dx.doi.org/10.3390/medicina57121376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704212/
https://www.ncbi.nlm.nih.gov/pubmed/34946320
http://dx.doi.org/10.3390/medicina57121376

Ejemplares similares